18 completed, 3 unknown, 1 terminated, 1 withdrawn. 23 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 23 | Completed 18, Unknown 3, Terminated 1, Withdrawn 1 |
Follow AIDS: new trials by email Literature Review of AIDS trials Research Report on AIDS
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| COVID-19 CoronaVac in Patients With Autoimmune Rheumatic Diseases and HIV/AIDS CoronaVac - Rheumatic Disease, HIV Infections | Phase 4 | Completed | University of Sao Paulo General Hospital | 2196 | 2021-02-09 | 2024-03-26 |
| Protect and Improve Cluster of Differentiation 4 (CD4) Cells and B Cells Lymphocytes Ahah Drug, Ahah Placebo - HIV-1-infection, AIDS | Phase 4 | Withdrawn | Trieu, Nguyen Thi, M.D. | 2020-09-20 | 2026-06-04 | |
| Effectiveness of a Smoking Cessation Algorithm Integrated Into HIV Primary Care Algorithm Treatment, Quitline only - HIV, AIDS | Phase 4 | Completed | University of Alabama at Birmingham | 371 | 2020-08-17 | 2026-05-22 |
| SSRI Effects on Depression and Immunity in HIV/AIDS Escitalopram, Placebo - Depression, HIV | Phase 4 | Completed | University of Pennsylvania | 108 | 2017-02-16 | 2024-05-07 |
| Pharmacokinetic Study of Super-boosted Lopinavir/Ritonavir Given With Rifampin Lopinavir/ritonavir and ritonavir - AIDS, Tuberculosis | Phase 4 | Terminated | University of Miami | 9 | 2016-02-01 | 2019-05-16 |
| Atripla to Stribild Switch Study to Evaluate Sleep Disturbances Stribild - HIV, AIDS | Phase 4 | Completed | Midtown Medical Center, Tampa, FL | 21 | 2015-02-01 | 2017-07-28 |
| Switching Undetectables to Selzentry Maraviroc - Human Immunodeficiency Virus, AIDS | Phase 4 | Completed | St. Hope Foundation | 31 | 2013-01-01 | 2014-11-19 |
| Maintenance Boosted Lopinavir Monotherapy Following Salvage Protease-inhibitor (PI) Based Regimen in HIV With Non-nucleoside Reverse Transcriptase Inhibitors (NNRTI) Based Regimen Failure Ritonavir-boosted lopinavir, optimized background regimens (OBRs) - HIV, AIDS | Phase 4 | Completed | Bamrasnaradura Infectious Diseases Institute | 63 | 2010-12-01 | 2013-05-13 |
| Cryptococcal Optimal ART Timing Trial efavirenz, nucleoside - Cryptococcal Meningitis, HIV Infections | Phase 4 | Completed | University of Minnesota | 177 | 2010-11-01 | 2020-06-09 |
| Maraviroc (Celsentri) With Raltegravir and Darunavir/Ritonavir for the Treatment of Triple Class Failure in Adult HIV-1 Infected Patients maraviroc, Raltegravir, Darunavir/ritonavir - HIV-1 Adults Patients, AIDS | Phase 4 | Unknown | Fundación Huésped | 60 | 2010-02-01 | 2010-02-10 |
| Genotype Based Personalized Prescription of Nevirapine Genetic test for NVP induced rash, 3TC/D4T/NVP or 3TC/AZT/NVP - Nevirapine Induced Rash, Nevirapine Induced Hepatitis | Phase 4 | Completed | Surakameth Mahasirimongkol | 1200 | 2009-07-01 | 2013-04-22 |
| Study To Investigate The Hemodynamic Effects Of Single Dose Vardenafil In Subjects Receiving Maraviroc Maraviroc, Vardenafil, Placebo - AIDS | Phase 4 | Completed | ViiV Healthcare | 18 | 2008-04-01 | 2013-01-25 |
| Omega-3 Fatty Acids for High Triglycerides in HIV-infected Patients Omega-3 fatty acid administration, Placebo - HIV Infections, AIDS | Phase 4 | Completed | Brown, Todd, M.D., Ph.D. | 48 | 2006-10-01 | 2014-11-05 |
| A Comparison Study of Kaletra Soft-Gel Capsules and Kaletra Tablets in an African American Cohort Kaletra soft-gel capsules switched to Kaletra tablets, MOS-HIV Health and Medication Satisfaction Survey, Global Conditioning Improvement and Therapy Preference Questionnaire - HIV-1, AIDS | Phase 4 | Completed | AIDS Arms Inc. | 120 | 2005-12-01 | 2007-04-05 |
| Buprenorphine and Integrated HIV Care Physician Management, Counseling - Substance-related Disorders, Drug Addiction | Phase 4 | Completed | Yale University | 52 | 2005-09-01 | 2020-04-03 |
| Buprenorphine and Integrated HIV Care Evaluation Buprenorphine, Integrated HIV care and office-based opioid dependence treatment - Opioid-Related Disorders, HIV Infections | Phase 4 | Unknown | The New York Academy of Medicine | 1350 | 2005-08-01 | 2007-03-27 |
| Once Daily 3TC, Efavirenz and ddI for HIV Infection once daily minimum 3-drug regimen of anti-retroviral medications - HIV Infection, AIDS | Phase 4 | Unknown | 407 Doctors | 120 | 2004-05-01 | 2005-10-25 |
| To Assess Compliance With a Once-daily Regimen of Lamivudine, Efavirenz and Didanosine Compliance - AIDS | Phase 4 | Completed | Bristol-Myers Squibb | 120 | 2004-04-01 | 2011-04-22 |
| Treatment of Cerebral Toxoplasmosis in HIV/AIDS TMX-SMX (Bactrim(R)), Pyrimethamine plus Sulfadiazine plus leucoverin - Toxoplasmic Encephalitis, AIDS | Phase 4 | Completed | Department of Medical Services Ministry of Public Health of Thailand | 30 | 2003-05-01 | 2007-07-31 |
| HIV/AIDS Kaposis Sarcoma: Comparison of Response to HAART vs HAART Plus CXT Generic HAART Triomune : d4T, 3TC, NVP, Generic HAART Triomune : d4T, 3TC, NVP and chemotherapy ABV - HIV, AIDS | Phase 4 | Completed | University of KwaZulu | 112 | 2003-01-01 | 2010-07-21 |
Showing 20 of 23. Sign in to see all of them.
Acquired Immunodeficiency Syndrome (23) · HIV Infections (9) · Opioid-Related Disorders (2) · Substance-Related Disorders (2) · Acidosis, Lactic (1) · Arthritis, Rheumatoid (1) · COVID-19 (1) · Cryptococcosis (1) · Depression (1) · Dyslipidemias (1) · Hepatitis (1) · Hypertriglyceridemia (1) · Inflammation (1) · Insulin Resistance (1) · Lipodystrophy (1)
Blood-Borne Infections (23) · Communicable Diseases (23) · Genital Diseases (23) · Immune System Diseases (23) · Immunologic Deficiency Syndromes (23) · Infections (23) · Lentivirus Infections (23) · RNA Virus Infections (23) · Retroviridae Infections (23) · Sexually Transmitted Diseases (23) · Sexually Transmitted Diseases, Viral (23) · Slow Virus Diseases (23) · Urogenital Diseases (23) · Virus Diseases (23) · HIV Infections (14)
Maraviroc (3) · Lamivudine (2) · Ritonavir (2) · efavirenz (2) · A1A0 ATPase, Methanosarcina mazei (1) · Buprenorphine (1) · Carnitine (1) · Compliance (1) · Counseling (1) · Darunavir (1) · Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination (1) · Escitalopram (1) · Genetic Testing (1) · Nevirapine (1) · Nucleosides (1)
Bristol-Myers Squibb (2) · 407 Doctors (1) · AIDS Arms Inc. (1) · Bamrasnaradura Infectious Diseases Institute (1) · Brown, Todd, M.D., Ph.D. (1) · Centers for Disease Control and Prevention (1) · Department of Medical Services Ministry of Public Health of Thailand (1) · Fundación Huésped (1) · Midtown Medical Center, Tampa, FL (1) · Queen's University (1) · St. Hope Foundation (1) · Surakameth Mahasirimongkol (1) · The New York Academy of Medicine (1) · Trieu, Nguyen Thi, M.D. (1) · University of Alabama at Birmingham (1)
United States (8) · Thailand (3) · Brazil (2) · South Africa (2) · Argentina (1) · Australia (1) · Belgium (1) · Canada (1) · Kenya (1) · Uganda (1) · Vietnam (1)
Adrian S Dobs, MD (1) · Anisa Mosam, FC Derm,PhD (1) · Catherine Boulanger, MD. (1) · Christopher J Cutter, Ph.D. (1) · David A Baker, MB ChB (1) · David Fiellin, MD (1) · David Leaf, MD (1) · David R Boulware, MD, MPH (1) · Dwight L Evans, MD (1) · Edward W Braun, MD (1) · Joseph Timpone, MD (1) · Krittaecho Siripassorn, MD (1) · Marsden K. Rawlings, MD (1)
PMID 15633090, PMID 15652610, PMID 15750399, PMID 17269969, PMID 17517949, PMID 20133267, PMID 23683266, PMID 24963568, PMID 30325463, PMID 30354935, PMID 31319498, PMID 31504335, PMID 31704214, PMID 32843994, PMID 34331051, PMID 34664616, PMID 34806342, PMID 34894235, PMID 34901885, PMID 34954325, PMID 35135832, PMID 35193873, PMID 35277389, PMID 35306594, PMID 35639644, PMID 35844042, PMID 36150668, PMID 36192386, PMID 36529052, PMID 36870351, PMID 37291679, PMID 39972326, PMID 42261247
K23AT002862 (1), R01DA044112 (1), U01AI089244 (1)